Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R. Holman, Adrian F. Hernandez, Vivian P. Thompson et al.|New England Journal of Medicine|2017Cited by 2.1k
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysisM. Angelyn Bethel, Rury R. Holman, Rishi Patel et al.|The Lancet Diabetes & Endocrinology|2017Cited by 591